Adjunctive clindamycin therapy in invasive β-haemolytic streptococcal infections - Authors' reply
- PMID: 34051182
- DOI: 10.1016/S1473-3099(21)00259-0
Adjunctive clindamycin therapy in invasive β-haemolytic streptococcal infections - Authors' reply
Conflict of interest statement
We declare no competing interests. The opinions expressed in this Correspondence are those of the authors and do not represent any position or policy of the National Institutes of Health, the US Department of Health and Human Services, or the US Government.
Comment on
-
Effectiveness of adjunctive clindamycin in β-lactam antibiotic-treated patients with invasive β-haemolytic streptococcal infections in US hospitals: a retrospective multicentre cohort study.Lancet Infect Dis. 2021 May;21(5):697-710. doi: 10.1016/S1473-3099(20)30523-5. Epub 2020 Dec 14. Lancet Infect Dis. 2021. PMID: 33333013 Free PMC article. Review.
-
Adjunctive clindamycin therapy in invasive β-haemolytic streptococcal infections.Lancet Infect Dis. 2021 Jun;21(6):762. doi: 10.1016/S1473-3099(21)00198-5. Lancet Infect Dis. 2021. PMID: 34051183 No abstract available.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
